Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis

NCT00027443 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Myocarditis

Interventions

DRUG: Muromonab-CD3
DRUG: Cyclosporine

Sponsor

Mayo Clinic